1
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
754,106
$55.1m39.65%
39.65%
Reduced Shares held: Q2 2021 796.1k, Q3 2021 796.1k, Q4 2021 766.1k, Q1 2022 754.1k
-12.0k
-12,000
-1.6%
2
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
89,240
$8.4m6.02%
6.02%
Added Shares held: Q2 2021 80.2k, Q3 2021 80.2k, Q4 2021 89.2k, Q1 2022 89.2k
+40
+40
0.0%
3
ELUTIA INC
CL A COM
ELUT
ELUT
1,417,923
$8.3m5.96%
5.96%
Unchanged Shares held: Q2 2021 30.0k, Q3 2021 50.0k, Q4 2021 1.4m, Q1 2022 1.4m
4
QUIDEL CORP
COM
QDEL
QDEL
59,684
$6.7m4.83%
4.83%
Unchanged Shares held: Q2 2021 59.7k, Q3 2021 59.7k, Q4 2021 59.7k, Q1 2022 59.7k
5
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
199,400
$4.8m3.48%
3.48%
Unchanged Shares held: Q2 2021 199.4k, Q3 2021 199.4k, Q4 2021 199.4k, Q1 2022 199.4k
6
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
294,143
$4.5m3.23%
3.23%
Reduced Shares held: Q2 2021 314.1k, Q3 2021 314.1k, Q4 2021 314.1k, Q1 2022 294.1k
-20.0k
-20,000
-6.4%
7
ALBIREO PHARMA INC
COM
BIOD
BIOD
113,000
$3.4m2.43%
2.43%
Unchanged Shares held: Q2 2021 111.0k, Q3 2021 113.0k, Q4 2021 113.0k, Q1 2022 113.0k
8
ACCELERATE DIAGNOSTICS INC
COM
COM
2,252,388
$3.2m2.33%
2.33%
Unchanged Shares held: Q2 2021 2.2m, Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m
9
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
18,000
$3.2m2.32%
2.32%
Unchanged Shares held: Q2 2021 18.0k, Q3 2021 18.0k, Q4 2021 18.0k, Q1 2022 18.0k
10
CONTINENTAL RES INC
COM
CLR
CLR
38,600
$2.4m1.70%
1.70%
Unchanged Shares held: Q2 2021 38.6k, Q3 2021 38.6k, Q4 2021 38.6k, Q1 2022 38.6k
11
BIOGEN INC
COM
BIIB
BIIB
10,100
$2.1m1.53%
1.53%
Reduced Shares held: Q2 2021 12.1k, Q3 2021 12.6k, Q4 2021 12.6k, Q1 2022 10.1k
-2.5k
-2,500
-19.8%
12
BIODESIX INC
COM
COM
1,252,753
$2.1m1.52%
1.52%
Unchanged Shares held: Q2 2021 1.1m, Q3 2021 1.1m, Q4 2021 1.3m, Q1 2022 1.3m
13
KARYOPHARM THERAPEUTICS INC
COM
COM
269,332
$2.0m1.43%
1.43%
Added Shares held: Q2 2021 230.0k, Q3 2021 246.0k, Q4 2021 246.0k, Q1 2022 269.3k
+23.3k
+23,332
9.5%
14
OVINTIV INC
COM
OVV
OVV
34,200
$1.8m1.33%
1.33%
Unchanged Shares held: Q2 2021 34.2k, Q3 2021 34.2k, Q4 2021 34.2k, Q1 2022 34.2k
15
BIOHAVEN PHARMACTL HLDG CO L
COM
BHVN
BHVN
14,000
$1.7m1.20%
1.20%
Added Shares held: Q2 2021 10.0k, Q3 2021 10.0k, Q4 2021 12.0k, Q1 2022 14.0k
+2.0k
+2,000
16.7%
16
PROTHENA CORP PLC
SHS
PRTA
PRTA
41,978
$1.5m1.11%
1.11%
Added Shares held: Q2 2021 30.2k, Q3 2021 40.2k, Q4 2021 40.2k, Q1 2022 42.0k
+1.7k
+1,731
4.3%
17
MASIMO CORP
COM
MASI
MASI
9,280
$1.4m0.97%
0.97%
Added Shares held: Q2 2021 8.0k, Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 9.3k
+1.3k
+1,280
16.0%
18
ALKERMES PLC
SHS
ALKS
ALKS
50,000
$1.3m0.95%
0.95%
Unchanged Shares held: Q2 2021 50.0k, Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k
19
HARROW INC
COM
HROW
HROW
180,000
$1.2m0.88%
0.88%
Unchanged Shares held: Q2 2021 180.0k, Q3 2021 180.0k, Q4 2021 180.0k, Q1 2022 180.0k
20
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
50,000
$1.1m0.81%
0.81%
Unchanged Shares held: Q2 2021 50.0k, Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k
21
INHIBRX INC
COM
INBX
INBX
50,448
$1.1m0.81%
0.81%
Added Shares held: Q2 2021 0, Q3 2021 0, Q4 2021 40.0k, Q1 2022 50.4k
+10.4k
+10,448
26.1%
22
EQUITRANS MIDSTREAM CORP
COM
ETRN
ETRN
133,050
$1.1m0.81%
0.81%
Unchanged Shares held: Q2 2021 133.1k, Q3 2021 133.1k, Q4 2021 133.1k, Q1 2022 133.1k
23
GOSSAMER BIO INC
COM
GOSS
GOSS
129,088
$1.1m0.81%
0.81%
Added Shares held: Q2 2021 0, Q3 2021 40.0k, Q4 2021 100.0k, Q1 2022 129.1k
+29.1k
+29,088
29.1%
24
DOCGO INC
COM
DCGO
DCGO
110,000
$1.0m0.73%
0.73%
Added Shares held: Q2 2021 0, Q3 2021 0, Q4 2021 10.0k, Q1 2022 110.0k
+100.0k
+100,000
1000.0%
25
ARVINAS INC
COM
ARVN
ARVN
15,000
$1.0m0.73%
0.73%
Unchanged Shares held: Q2 2021 15.0k, Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k
26
AMARIN CORP PLC
SPONS ADR NEW
SPONS ADR NEW
300,000
$987.0k0.71%
0.71%
Unchanged Shares held: Q2 2021 300.0k, Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k
27
PIONEER NAT RES CO
COM
PXD
PXD
3,800
$950.0k0.68%
0.68%
Unchanged Shares held: Q2 2021 3.8k, Q3 2021 3.8k, Q4 2021 3.8k, Q1 2022 3.8k
28
CYTOKINETICS INC
COM NEW
CYTK
CYTK
25,000
$920.0k0.66%
0.66%
Unchanged Shares held: Q2 2021 10.0k, Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k
29
IMMUNOGEN INC
COM
IMGN
IMGN
190,000
$904.0k0.65%
0.65%
Unchanged Shares held: Q2 2021 190.0k, Q3 2021 190.0k, Q4 2021 190.0k, Q1 2022 190.0k
30
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
38,000
$900.0k0.65%
0.65%
Unchanged Shares held: Q2 2021 10.0k, Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k
31
SOLENO THERAPEUTICS INC
COM
COM
3,676,899
$820.0k0.59%
0.59%
Added Shares held: Q2 2021 876.9k, Q3 2021 876.9k, Q4 2021 876.9k, Q1 2022 3.7m
+2.8m
+2,800,000
319.3%
32
AVEO PHARMACEUTICALS INC
COM NEW
AVEO
AVEO
140,000
$783.0k0.56%
0.56%
Unchanged Shares held: Q2 2021 0, Q3 2021 40.0k, Q4 2021 140.0k, Q1 2022 140.0k
33
CONTRAFECT CORP
COM
CFRX
CFRX
200,000
$730.0k0.53%
0.53%
Unchanged Shares held: Q2 2021 200.0k, Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k
34
INARI MED INC
COM
NARI
NARI
8,000
$725.0k0.52%
0.52%
Added Shares held: Q2 2021 7.0k, Q3 2021 7.0k, Q4 2021 7.0k, Q1 2022 8.0k
+1.0k
+1,000
14.3%
35
NEKTAR THERAPEUTICS
COM
COM
128,000
$690.0k0.50%
0.50%
Added Shares held: Q2 2021 72.0k, Q3 2021 72.0k, Q4 2021 100.0k, Q1 2022 128.0k
+28.0k
+28,000
28.0%
36
IRHYTHM TECHNOLOGIES INC
COM
IRTC
IRTC
4,000
$630.0k0.45%
0.45%
Unchanged Shares held: Q2 2021 0, Q3 2021 4.0k, Q4 2021 4.0k, Q1 2022 4.0k
37
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
12,000
$610.0k0.44%
0.44%
Unchanged Shares held: Q2 2021 8.0k, Q3 2021 12.0k, Q4 2021 12.0k, Q1 2022 12.0k
38
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
40,000
$590.0k0.42%
0.42%
Unchanged Shares held: Q2 2021 40.0k, Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k
39
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
34,333
$586.0k0.42%
0.42%
Added Shares held: Q2 2021 0, Q3 2021 0, Q4 2021 28.0k, Q1 2022 34.3k
+6.3k
+6,334
22.6%
40
VANDA PHARMACEUTICALS INC
COM
VNDA
VNDA
50,000
$566.0k0.41%
0.41%
Reduced Shares held: Q2 2021 80.0k, Q3 2021 80.0k, Q4 2021 60.0k, Q1 2022 50.0k
-10.0k
-10,000
-16.7%
41
CHEMOCENTRYX INC
COM
CCXI
CCXI
20,000
$501.0k0.36%
0.36%
Unchanged Shares held: Q2 2021 30.0k, Q3 2021 25.0k, Q4 2021 20.0k, Q1 2022 20.0k
42
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
45,114
$472.0k0.34%
0.34%
Unchanged Shares held: Q2 2021 45.1k, Q3 2021 45.1k, Q4 2021 45.1k, Q1 2022 45.1k
43
SILK RD MED INC
COM
SILK
SILK
10,000
$413.0k0.30%
0.30%
Added Shares held: Q2 2021 0, Q3 2021 0, Q4 2021 8.0k, Q1 2022 10.0k
+2.0k
+2,000
25.0%
44
BLUEBIRD BIO INC
COM
COM
84,000
$407.0k0.29%
0.29%
Unchanged Shares held: Q2 2021 74.0k, Q3 2021 84.0k, Q4 2021 84.0k, Q1 2022 84.0k
45
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
8,000
$369.0k0.27%
0.27%
Unchanged Shares held: Q2 2021 8.0k, Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k
46
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
38,000
$360.0k0.26%
0.26%
Unchanged Shares held: Q2 2021 38.0k, Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k
47
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
25,000
$339.0k0.24%
0.24%
Unchanged Shares held: Q2 2021 0, Q3 2021 0, Q4 2021 25.0k, Q1 2022 25.0k
48
XENCOR INC
COM
XNCR
XNCR
12,300
$328.0k0.24%
0.24%
Unchanged Shares held: Q2 2021 12.3k, Q3 2021 12.3k, Q4 2021 12.3k, Q1 2022 12.3k
49
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
20,000
$325.0k0.23%
0.23%
Unchanged Shares held: Q2 2021 20.0k, Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k
50
STOKE THERAPEUTICS INC
COM
STOK
STOK
15,000
$316.0k0.23%
0.23%
Unchanged Shares held: Q2 2021 15.0k, Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k
51
G1 THERAPEUTICS INC
COM
GTHX
GTHX
40,000
$304.0k0.22%
0.22%
Unchanged Shares held: Q2 2021 40.0k, Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k
52
KINIKSA PHARMACEUTICALS LTD
COM CL A
COM CL A
30,000
$298.0k0.21%
0.21%
Unchanged Shares held: Q2 2021 20.0k, Q3 2021 30.0k, Q4 2021 30.0k, Q1 2022 30.0k
53
PHREESIA INC
COM
PHR
PHR
10,000
$264.0k0.19%
0.19%
New Shares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 10.0k
54
IVERIC BIO INC
COM
OPHT
OPHT
15,000
$252.0k0.18%
0.18%
Unchanged Shares held: Q2 2021 0, Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k
55
TURNING POINT THERAPEUTICS I
COM
COM
8,000
$215.0k0.15%
0.15%
Unchanged Shares held: Q2 2021 8.0k, Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k
56
INFLARX NV
COM
IFRX
IFRX
70,000
$128.0k0.09%
0.09%
Unchanged Shares held: Q2 2021 70.0k, Q3 2021 70.0k, Q4 2021 70.0k, Q1 2022 70.0k
57
ANGION BIOMEDICA CORP
COM
COM
54,392
$115.0k0.08%
0.08%
Unchanged Shares held: Q2 2021 60.6k, Q3 2021 54.4k, Q4 2021 54.4k, Q1 2022 54.4k
58
ASPIRA WOMENS HEALTH INC
COM
COM
103,104
$107.0k0.08%
0.08%
Unchanged Shares held: Q2 2021 103.1k, Q3 2021 103.1k, Q4 2021 103.1k, Q1 2022 103.1k
59
LAIRD SUPERFOOD INC
COM STK
LSF
LSF
28,000
$101.0k0.07%
0.07%
Added Shares held: Q2 2021 14.0k, Q3 2021 14.0k, Q4 2021 18.0k, Q1 2022 28.0k
+10.0k
+10,000
55.6%
60
YIELD10 BIOSCIENCE INC
COM
COM
18,750
$99.0k0.07%
0.07%
Unchanged Shares held: Q2 2021 0, Q3 2021 18.8k, Q4 2021 18.8k, Q1 2022 18.8k
61
SIENTRA INC
COM
SIEN
SIEN
40,000
$89.0k0.06%
0.06%
Unchanged Shares held: Q2 2021 40.0k, Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k
62
CONCERT PHARMACEUTICALS INC
COM
CNCE
CNCE
20,000
$67.0k0.05%
0.05%
Unchanged Shares held: Q2 2021 20.0k, Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k
63
AKEBIA THERAPEUTICS INC
COM
AKBA
AKBA
20,000
$14.0k0.01%
0.01%
Reduced Shares held: Q2 2021 100.0k, Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 20.0k
-80.0k
-80,000
-80.0%